Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by Staghorn69on May 23, 2018 7:11pm

140 Views

Post# 28072321

RE:RE:RE:Did You Notice CC Abbott’s “Disclosures”?

Biofinder wrote:

ilikethebible80 wrote:

Biofinder wrote: She/they no longer currently own any PLI shares. She/they must have sold all their PLI shares after the Ryplazim debacle.

Disclosure: I am/we are long AST, GWPH.

Additional disclosure: I/we have no positions in any stocks mentioned, but may initiate a long position in PFSCF within the next 6 months.

Biofinder, your presumption is not correct. I did not own any PLI shares at the time of the annouced delay.

Best regards,
CC Abbott

So you pump PLI in an article saying PLI is still a buy, then you dump your shares prior to the (FDA) Ryplazim delay announcement. Interesting. Good to know. Best regards back at ya.